ISIN | CH1205452688 |
---|---|
Valor Number | 120545268 |
Bloomberg Global ID | |
Fund Name | Bellevue Healthcare Strategy I2 EUR |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 972.04 EUR | 10.09.2025 |
---|---|---|
Previous Price * | 984.95 EUR | 09.09.2025 |
52 Week High * | 1,082.50 EUR | 05.02.2025 |
52 Week Low * | 914.32 EUR | 07.04.2025 |
NAV * | 972.04 EUR | 10.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 128,365,924 | |
Unit/Share Assets *** | 42,062,244 | |
Trading Information SIX |
YTD Performance | -5.30% |
31.12.2024 - 10.09.2025
31.12.2024 10.09.2025 |
---|---|---|
YTD Performance (in CHF) | -5.83% |
31.12.2024 - 10.09.2025
31.12.2024 10.09.2025 |
1 month | +4.31% |
11.08.2025 - 10.09.2025
11.08.2025 10.09.2025 |
3 months | -0.81% |
10.06.2025 - 10.09.2025
10.06.2025 10.09.2025 |
6 months | -3.27% |
10.03.2025 - 10.09.2025
10.03.2025 10.09.2025 |
1 year | -8.55% |
10.09.2024 - 10.09.2025
10.09.2024 10.09.2025 |
2 years | -1.57% |
11.09.2023 - 10.09.2025
11.09.2023 10.09.2025 |
3 years | -2.54% |
06.10.2022 - 10.09.2025
06.10.2022 10.09.2025 |
5 years | - | - |
Equity Participation Rate in % | 94.75 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Thermo Fisher Scientific Inc | 3.49% | |
---|---|---|
Galderma Group AG Registered Shares | 3.35% | |
Vertex Pharmaceuticals Inc | 3.25% | |
AbbVie Inc | 3.22% | |
Eli Lilly and Co | 3.14% | |
Stryker Corp | 3.06% | |
Abbott Laboratories | 3.04% | |
Boston Scientific Corp | 3.03% | |
McKesson Corp | 3.01% | |
Sandoz Group AG Registered Shares | 2.95% | |
Last data update | 31.07.2025 |
TER | 0.61% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |